A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT04575467
- Locations
- 🇦🇺
Investigational Site, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath